Imaging device maker GE Healthcare will broaden its breast cancer detection offerings through its acquisition of somo-v automated breast ultrasound system maker U-Systems Inc.for undisclosed terms, GE announced Nov. 9. Somo-v gained 510(k) clearance in 2005 for diagnostic use as an adjunct to X-ray mammography; in September the device gained PMA approval for breast cancer screening in asymptomatic dense-breasted women who have not had a previous clinical breast intervention following a negative mammogram screening. (See [A#01120924001].) It is the first ultrasound device available in the U.S. with a breast cancer screening indication, according to privately held U-Systems. “The combination of U-Systems and GE Healthcare uniquely positions GE to offer U.S. health care providers and their patients the most comprehensive portfolio of breast care innovations on the market – from screening to diagnosis to monitoring,” said GE Healthcare CEO Tom Gentile. “In addition to digital mammography and breast MR, GE can now offer breast screening ultrasound technology to our customers to help in early detection, which provides for more treatment options.”
Ophthalmic device maker Bausch & Lomb Inc. will acquire the remaining shares of eye laser firm Technolas Perfect Vision GMBH that it does not already own for undisclosed...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
